Patient Perspectives on Gene Transfer Therapy for Sickle Cell Disease
ConclusionOlder adults had more desire to participate in human clinical GTT trials than younger participants. When recruiting for trials, researchers should develop GTT educational materials that address participant lack of trust in the healthcare system, cultural beliefs, fears related to side effects, and include visual illustrations. Use of such materials will provide adults with SCD the information they need to fully evaluate GTT.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Alopecia | Bone Marrow Transplant | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Chemotherapy | Clinical Trials | Drugs & Pharmacology | Education | Genetics | Infertility | Reproduction Medicine | Sickle Cell Anemia | Study | Transplants | Universities & Medical Training